Stay updated with breaking news from Occlutech group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
El regulador de flujo auricular (AFR) de Occlutech recibe la designación de dispositivo innovador de la FDA de los Estados Unidos prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Occlutech s Atrial Flow Regulator (AFR) Receives U.S. FDA Breakthrough Device Designation SCHAFFHAUSEN, Switzerland, Dec. 18, 2020 /PRNewswire/ Occlutech, a privately-held company, announced today that the US Food and Drug Administration (FDA) has granted the company a Breakthrough Device designation for its first-in-class, implantable Atrial Flow Regulator (AFR) for Pulmonary Arterial Hypertension (PAH). PAH affects hundreds of thousands in the U.S. and globally and is resulting from changes in cells that causes damages of the lung arteries. Consequentially, the heart is forced to work harder to supply enough oxygen. The patient experiences symptoms such as shortness of breath, dizziness and fatigue. The severity of these symptoms usually correlates with progression of the disease and significantly reduced quality of life. Over time, the right ventricle enlarges to hold more blood and the additional strain gradually causes the heart to fail. By placing the Occlutech AF ....
Occlutech's Atrial Flow Regulator (AFR) Receives U.S. FDA Breakthrough Device Designation | ANP Pers Support perssupport.nl - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from perssupport.nl Daily Mail and Mail on Sunday newspapers.